Purpose
Coqui RadioPharmaceuticals Corporation (Coqui) has requested this meeting to discuss the application of regulatory guidance
documents to the design of its proposed medical isotope production facility. Specific topics include design considerations for flooding, seismic activity, karst formations, normal and emergency power systems, engineered safety features, and items
relied on for safety.
documents to the design of its proposed medical isotope production facility. Specific topics include design considerations for flooding, seismic activity, karst formations, normal and emergency power systems, engineered safety features, and items
relied on for safety.
Meeting Feedback
Meeting Dates and Times
* Date/Time Change *
10/07/14, 1PM - 3PM EDT
Meeting Location
One White Flint
11555 Rockville Pike
4-B06
Rockville, MD
Contact
Steven T. Lynch
(301) 415-1524
Eben S. Allen
(301) 415-4246
Participation Level
Category 1
NRC Participants
Office of Nuclear Reactor Regulation
Office of Nuclear Material Safety and Safeguards
External Participants
Enercon
Coqui Radiopharmaceuticals Corporation
A. Adams
A. Roma
A. Valderrabano
C. Bigles
G. Cassini
K. Folk
M. Adams
M. Tynan
R. McGoey
S. Blanchard
S. Lynch
V. Garea
W. Schuster
Gresham
Hogan Lovells
INVAP